Merck Abandons New Hepatitis C Drugs

Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and determining an abundance of treatments were already available.

from WSJ.com: US Business http://ift.tt/2ka03wF
via IFTTT